
CDCR
Questions over the origins and quality of execution drugs continue
For the past couple of months, the ACLU of Northern California has been pulling together public records that shed light on US states’ search for execution drugs abroad. Arizona and California both ordered the anesthetic sodium thiopental (one of three drugs used in the states’ lethal injection procedures) from a company in the United Kingdom. Going abroad for the drug was the only option for getting ahold of it at the time, these states determined, because Hospira, the sole US manufacturer of the drug–and the only one approved by the FDA–had halted production after running up against a raw materials shortage. (Now, incidentally, Hospira has said they won’t make the drug at all due to international controversy over its use in executions.) Because the drugs were brought in from abroad and because the FDA has not approved any foreign manufacturers of sodium thiopental, a lot of scrutiny has been put on the role of the FDA in sanctioning or not sanctioning these imports. In response to their role in vetting lethal injection products, the FDA said they’ve released all shipments of foreign sodium thiopental bound for California and Arizona with the following accompanying statement:




The California Department of Corrections and rehabilitation has revealed some information on the source of its recently acquired supplies of sodium thiopental, a lethal injection drug that’s been scarce nationwide.
